Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Quantification of Parkinson's Disease Patients as a Biomarker for Classification, Prediction and Response to Treatment

NCT: NCT06586320 · ENROLLING_BY_INVITATION

NCT IDNCT06586320
StatusENROLLING_BY_INVITATION
Start Date2025-02-06
Completion2027-02-01
SponsorStardots AB (INDUSTRY)
First posted
Last updated

Brief Summary

This is a three-armed open investigational study that aims to differentiate, quantify, and categorize abnormal eye movements and upper limbs movements in patients with Parkinson's disease. The study is using investigational non-invasive devices for that reason including ANLIVA® Hand Movement and ANLIVA® Eye Movement.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑